NM_201596.3:c.380C>T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_201596.3(CACNB2):c.380C>T(p.Ala127Val) variant causes a missense change. The variant allele was found at a frequency of 0.000154 in 1,613,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_201596.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB2 | ENST00000324631.13 | c.380C>T | p.Ala127Val | missense_variant | Exon 4 of 14 | 1 | NM_201596.3 | ENSP00000320025.8 | ||
CACNB2 | ENST00000377329.10 | c.218C>T | p.Ala73Val | missense_variant | Exon 3 of 13 | 1 | NM_201590.3 | ENSP00000366546.4 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251320Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135832
GnomAD4 exome AF: 0.000147 AC: 215AN: 1461706Hom.: 0 Cov.: 31 AF XY: 0.000144 AC XY: 105AN XY: 727172
GnomAD4 genome AF: 0.000217 AC: 33AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74478
ClinVar
Submissions by phenotype
Brugada syndrome 4 Uncertain:3Benign:1
- -
Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as 3C-VUS. Following criteria are met: 0105 - The mechanism of disease for this gene is not clearly established. (I) 0111 - The inheritance pattern for this gene is unknown. Inheritance information not provided by OMIM and ClinGen dispute the association of CACNB2 with Brugada syndrome. (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to valine. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (31 heterozygotes, 0 homozygotes). (I) 0309 - Alternative amino acid changes at the same position has been observed in gnomAD (v2 & v3) (1 heterozygote, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated SH3 domain (PDB). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been reported in a patient with idiopathic ventricular fibrillation (PMID: 20817017), and has also been classified as likely benign (PMID: 25637381). This variant has one benign, one likely benign, and six VUS entries in ClinVar. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) NB: This variant has been reclassified as a VUS with low clinical relevance. It was previously reported as NM_000724.3(CACNB2):c.215C>T; p.(Ala72Val). -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 73 of the CACNB2 protein (p.Ala73Val). This variant is present in population databases (rs200367454, gnomAD 0.02%). This missense change has been observed in individual(s) with idiopathic ventricular fibrillation (PMID: 20817017). ClinVar contains an entry for this variant (Variation ID: 161209). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNB2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: HGMD 1 proband with early repolarization syndrome. LB in Amendola 2015. ClinVar 1 star review Ambry VUS, ESP LB -
Sudden unexplained death Uncertain:1
CACNB2 Ala72Val has been previously reported in a case of idiopathic VF (Burashnikov E, et al., 2010) but has also been classified as likely benign in a study on the NHLBI exome sequencing project (Amendola LM, et al., 2015). We identified this variant in a sudden unexplained death case. The variant is present in the Genome Aggregation Database (MAF= 0.00009, http://gnomad.broadinstitute.org/), at an allele frequency which is higher then expected for an arrhythmia syndrome. In silico tools SIFT, PolyPhen-2 and MutationTaster predict this variant to be deleterious. In summary, the variant is seen at an elevated frequency in the general population but in silico tools predict it to be deleterious, therefore we classify CACNB2 Ala72Val as a variant of 'uncertain significance'. -
not provided Uncertain:1
Reported in one individual with idiopathic ventricular fibrillation (PMID: 20817017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (Richards et al., 2015); This variant is associated with the following publications: (PMID: 25637381, 26707467, 20817017) -
Paroxysmal familial ventricular fibrillation Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at